Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Current Medicinal Chemistry|April 8, 2003
Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agentsC Boss, S Richard-Bildstein, T Weller, et al.
The Journal of Biological Chemistry|November 15, 1992
Nonproteolytic "activation" of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibodyF H Derkx, J Deinum, M Lipovski, et al.
Journal of Cardiovascular Pharmacology|November 5, 1999
Renal vascular and biochemical responses to systemic renin inhibition in dogs at low renal perfusion pressureJ P Clozel, M M Véniant, C Qiu, et al.
Journal of Cardiovascular Pharmacology|December 1, 1992
Neurohormonal and blood pressure responses to low-dose infusion of an orally active renin inhibitor, Ro 42-5892, in salt-replete menJ K Doig, R J MacFadyen, P A Meredith, et al.
Experimental Gerontology|February 15, 2000
Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear diseaseM Clozel, P Hess, W Fischli, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 1991
Ro 42-5892 is a potent orally active renin inhibitor in primatesW Fischli, J P Clozel, K el Amrani, et al.
Hypertension (Dallas, Tex. : 1979)|February 4, 1999
Effects of human prorenin in rats transgenic for human angiotensinogenD N Müller, K F Hilgers, S Mathews, et al.
Circulation Research|February 1, 1997
Functional and biochemical analysis of angiotensin II-forming pathways in the human heartA Wolny, J P Clozel, J Rein, et al.
Pageof 6